Multi-super specialty care · Bhubaneswar

Dr. Priya Priyadarshini Nayak

Dr. Priya Priyadarshini Nayak

MD (General Medicine), DrNB medical oncology
Senior Consultant

OPD Days & Timings

Monday to Saturday, 9:30 AM – 5:30 PM (Except Public Holidays)

Doctor Experience

Dr. Priya Priyadarshini Nayak, Senior Consultant Medical Oncology, Sum Ultimate Medicare has completed her post graduation in Internal Medicine from VMMC & Safdarjung Hospital and did her DrNB in Medical Oncology from Medanta, The Medicity in Gurugram. She has a huge experience in treating solid tumor, Breast Cancer & Gynecological Malignancies, Head & Neck Malignancies, Lungs Malignancies, Gastro Intestinal Malignancies, Sarcoma, Leukemia and Lymphomas. She is also a part in Bone marrow Transplant (both allogenic & auto transplant). After her tenure in Medanta, she joined in IMS & Sum Hospital as Associate Professor in the dept. of Medical Oncology. She has been associated with numerous national and international. Conferences and has large number of research publications to her credit. She has many clinical trails where running under her where she is a principal investigator. Her contribution in organizing cancer awareness programs through media is significant. Her participation in cancer camps in different parts of the state is significant.

Expertise

  • Breast Cancer & Gynaecological Malignancies
  • Head & Neck Malignancies
  • Lung Malignancies
  • Gastrointestinal Malignancies
  • Sarcoma
  • Leukemia & Lymphomas

Awards

Odisha Adarsh Samman, 2025.

News16 Award, 2025.

World Woman Leadership Congress Award, 2022.

Corporate Icon Award - My City Links, 2022.

Paper Presentation

1. Nayak PP, Swain SK, Uthansingh K, Sahu MC. Clinical and pathological features in cases of locally advanced breast carcinoma: a prospective observational study. Romanian Medical Journal. 2025;72(1):79–89. doi:10.37897/RMJ.2025.1.15. (First and corresponding author.)

2. Parikh PM, Biswas G, Dhamne NA, et al. Practical Consensus Guidelines on the Use of Cetuximab in Head and Neck Squamous Cell Carcinoma (HNSCC). South Asian Journal of Cancer. 2025;14(1):90–102. doi:10.1055/s-0044-1791783. (Co-author.)

3. Prabhash K, Saha R, Nayak PP, et al. Efficacy and Safety of Biosimilar Cetuximab (CETUXA) in Locoregionally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck: A Retrospective Multicenter Analysis. Journal of Carcinogenesis. 2025;24(10s):382–389. (Co-author; 505-patient multicentre study.)

Other earlier publications and book chapter

1. Understanding Glycosylated Haemoglobin. Review article. 2014. Reference recorded in earlier CV: medind.nic.in/jac/t14/i3/jact14i3p220.pdf.

2. Hemophagocytic syndrome. Book chapter in The Textbook of Critical Care Including Trauma and Emergency Care. Jaypee Publications.

3. Safety and feasibility of PICC in children with cancer: Experience in a research limited setting. Indian Journal of Applied Research.

4. Evaluation of Iron Status in Patients of Solid Organ Malignancies: Study from a Cancer Research Centre. Publication date recorded in earlier CV: 11 September 2019.

5. Epigenome, Microbiome, and Metabolites: Unraveling the Complex Pathogenesis of Celiac Disease. Cell Biology International. DOI: 10.1002/cbin.70231.

6. The Microbiome in Glioblastoma: Mechanisms, Tumor–Immune Interactions, and Translational Perspectives. MicrobiologyOpen. DOI: 10.1002/mbo3.70431.

7. NRF2-Regulated Ferroptosis in Breast Cancer: Mechanisms, Resistance, and Therapeutic Opportunities. Asia-Pacific Journal of Clinical Oncology. DOI: 10.1111/ajco.70195.

8. Tumor-Associated Macrophages in the Chemoresistant Microenvironment of Gastric Cancer: Key Mechanisms and Intercellular Crosstalk. Cell Biology International. DOI: 10.1002/cbin.70203.

9. Ginsenosides as Emerging Adjuvants for Immunotherapy in Gastrointestinal Cancers. Journal of Gastroenterology and Hepatology. DOI: 10.1111/jgh.70333.

10. Exosome-Based Strategies in Hepatocellular Carcinoma: Mechanisms, Immunotherapy, and Clinical Challenges. Journal of Gastroenterology and Hepatology. DOI: 10.1111/jgh.70245.

11. Nanomedicine Strategies Against Biofilm-Associated Infections: Advances, Challenges, and Translational Barriers. MicrobiologyOpen. DOI: 10.1002/mbo3.70210.

12. Circulating Tumor Cells as Diagnostic and Therapeutic Biomarkers in Hepatocellular Carcinoma: Advancing Precision Oncology Through Liquid Biopsy. Journal of Gastroenterology and Hepatology. Article ID: JGH70197.

13. Hypercalcemia of malignancy: Time to pull the brakes. Indian surjoncol.Jun 11;13 (i) : 28-32-doi